“Friends and foes” of multiple myeloma measurable/minimal residual disease evaluation by next generation flow

Next Generation Flow (NGF) represents a gold standard for the evaluation of Minimal Residual Disease (MRD) in Multiple Myeloma (MM) patients at any stage of treatment. Although the assessment of MRD is still not universally employed in clinical practice, numerous studies have demonstrated the streng...

Descripción completa

Detalles Bibliográficos
Autores principales: Pacelli, Paola, Raspadori, Donatella, Bestoso, Elena, Gozzetti, Alessandro, Bocchia, Monica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742464/
https://www.ncbi.nlm.nih.gov/pubmed/36518304
http://dx.doi.org/10.3389/fonc.2022.1057713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742464/
https://www.ncbi.nlm.nih.gov/pubmed/36518304
http://dx.doi.org/10.3389/fonc.2022.1057713

Ejemplares similares